Tag: Relapsed Refractory NHL Treatment

Home / Relapsed Refractory NHL Treatment

Categories

A study of chimeric antigen receptor T lymphocytes (CAR-T) in the treatment of relapsed and refractory non-Hodgkin lymphoma

Detailed Description: This is a single-center, single-arm, open-label study. After meeting the eligibility criteria and enrolling on the trial, patients will undergo leukapheresis for collect...
relapsed-refractory-nhl-treatment

Scan the code